Evidence map›Paper›PMID 32772930›Full record

ReviewJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2020

Society for Cardiovascular Magnetic Resonance (SCMR) guidance for re-activation of cardiovascular magnetic resonance practice after peak phase of the COVID-19 pandemic.

Bradley D Allen, Timothy C Wong, Chiara Bucciarelli-Ducci, Jennifer Bryant, Tiffany Chen, Erica Dall'Armellina, J Paul Finn, Marianna Fontana, Marco Francone, Yuchi Han and 11 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2023
    Review
  3. Review
  4. T2 mapping in myocardial disease: a comprehensive review.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Review
  5. 2021 - State of our JCMR.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Imaging in COVID-19-related myocardial injury.The international journal of cardiovascular imaging · 2021
    Review
  12. Review
  13. 2020 - State of our JCMR.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Bradley D AllenDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. bdallen@northwestern.edu.ORCID 0000-0002-0667-137X
Timothy C WongDepartment of Medicine (Cardiology), University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Chiara Bucciarelli-DucciBristol Heart Institute, Bristol NIHR Biomedical Research Centre, University Hospitals Bristol and University of Bristol, Bristol, UK.
Jennifer BryantNational Heart Research Institute Singapore, National Heart Center Singapore, 5 Hospital Drive, Singapore, Singapore.
Tiffany ChenCardiovascular Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Erica Dall'ArmellinaLeeds Institute of Cardiovascular and Metabolic Medicine, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK.
J Paul FinnDepartments of Radiology and Medicine, UCLA, Los Angeles, California, USA.
Marianna FontanaDivision of Medicine, University College London, London, UK.
Marco FranconeDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Yuchi HanDepartments of Medicine (Cardiovascular Division) and Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Allison G HaysDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Ron JacobThe Heart and Vascular Institute, Lancaster General Health/PENN Medicine, Lancaster, PA, USA.
Chris LawtonBristol Heart Institute, Bristol NIHR Biomedical Research Centre, University Hospitals Bristol and University of Bristol, Bristol, UK.
Warren J ManningDepartments of Medicine (Cardiovascular Division) and Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Karen OrdovasDepartments of Radiology and Medicine, University of California, San Francisco, San Francisco, California, USA.
Purvi ParwaniDepartment of Medicine (Cardiology), Loma Linda University, Loma Linda, California, USA.
Sven PleinLeeds Institute of Cardiovascular and Metabolic Medicine, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK.
Andrew J PowellDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Subha V RamanKrannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Michael SalernoDepartments of Medicine, Radiology, and Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
James C CarrDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Funding

Imaging-based Indentification of Premature Ventricular Contraction-mediatedR01HL148103 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HAN, YUCHI · 2020 to 2025
$2.8M
NHLBI NIH HHS R01 HL148103
6 · The paper itself

Abstract

During the peak phase of the COVID-19 pandemic, alterations of standard operating procedures were necessary for health systems to protect patients and healthcare workers and ensure access to vital hospital resources. As the peak phase passes, re-activation plans are required to safely manage increasing clinical volumes. In the context of cardiovascular magnetic resonance (CMR), re-activation objectives include continued performance of urgent CMR studies and resumption of CMR in patients with semi-urgent and elective indications in an environment that is safe for both patients and health care workers.

Indexed as

BetacoronavirusPractice Guidelines as TopicCardiovascular DiseasesCardiovascular SystemCoronavirus InfectionsCOVID-19HumansMagnetic Resonance ImagingPandemicsPneumonia, ViralPredictive Value of TestsSARS-CoV-2Societies, MedicalCardiovascular magnetic resonanceCOVID-19SafetyWorkflow

Identifiers

PMID32772930
PMCPMC7415346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.